Underwriters at Lloyd's Subscribing to Cover Note B1526MACAR1800089 v. TCSL, Inc.

District Court, N.D. California·Decided June 15, 2020·No. 4:19-cv-02945·Unknown

Opinion

1 2 3

SUBSCRIBING TO COVER NOTE Case No. 19-cv-02945-PJH 8 B1526MACAR1800089,

9 Plaintiff, ORDER GRANTING MOTION FOR LEAVE TO AMEND; DENYING 10 v. WITHOUT PREJUDICE MOTION TO DISMISS; AND DENYING MOTION 11 ABAXIS, INC., et al., FOR LEAVE TO RESPOND 12 Defendants. Re: Dkt. Nos. 67, 68, 75

14 15 Before the court is defendants Abaxis, Inc. (“Abaxis”) and Zoetis, Inc.’s (“Zoetis” 16 and together with Abaxis, “defendants”) motion for leave to file a second amended 17 answer and crossclaim. Also before the court are cross-defendant C.H. Robinson 18 Worldwide, Inc.’s (“CHR” or “cross-defendant”) motion to dismiss and plaintiff 19 Underwriters at Lloyd’s Subscribing to Cover Note B1526MACAR1800089’s 20 (“Underwriters” or “plaintiff”) motion for leave to respond. The matters are fully briefed 21 and suitable for decision without oral argument. Having read the parties’ papers and 22 carefully considered their arguments and the relevant legal authority, and good cause 23 appearing, the court hereby rules as follows. 25 The complaint in this action was filed by plaintiff on May 29, 2019. Dkt. 1. This 26 court’s April 6, 2020 order contains a more thorough recitation of the underlying factual 27 background of this case. See Dkt. 63. To briefly summarize, this case involves the 1 (defendants) to Henry Schein Animal Health and Butler Animal Health Supply, LLC 2 (“Schein”), products that were ruined en route to Schein. See id. at 2. Plaintiff is a group 3 of insurers that paid out Schein’s insurance claim and now asserts that party’s claims. 4 TCSL, Inc.1 (“TCSL”) was the carrier of the shipment in question and CHR was alleged to 5 have issued the bill of lading and coordinated communication between TCSL and Schein. 6 Id. 7 The relevant procedural history is as follows. On June 26, 2019, plaintiff filed a 8 first amended complaint (Dkt. 16), to which defendants Abaxis and Zoetis filed a motion 9 to dismiss (Dkt. 20). Upon the parties’ stipulation, plaintiff filed the operative Second 10 Amended Complaint (“SAC”) and defendants agreed to refile their motion to dismiss. 11 The SAC dismissed two of three claims alleged against Abaxis and Zoetis, leaving only a 12 breach of contract claim pled against them. Dkt. 28. On September 23, 2019, plaintiff 13 voluntarily dismissed all claims against TCSL. (Dkt. 35), and on October 17, 2019, 14 plaintiff voluntarily dismissed all claims against CHR pursuant to a settlement agreement, 15 (Dkt. 38). 16 On November 20, 2019, this court denied defendants Abaxis and Zoetis’s motion 17 to dismiss (Dkt. 40), and then on December 4, 2019, defendants filed an answer to the 18 SAC and crossclaims (“Crossclaim”) against TCSL and CHR (Dkt. 42). The Crossclaim 19 against CHR incorporated by reference the allegations in the SAC and further alleged 20 that TCSL, acting at the direction of or in conjunction with CHR, negligently mishandled 21 the shipment of pharmaceuticals obtained from Abaxis. Crossclaim ¶ 20. In response to 22 defendants’ Crossclaim, CHR filed a Rule 12(b)(6) motion to dismiss. Dkt. 42. On April 23 6, 2020, this court granted CHR’s motion and granted leave to amend the crossclaim 24 within twenty-one days. Dkt. 63. 25 On April 27, 2020, defendants Abaxis and Zoetis filed their First Amended Answer 26 and Crossclaim (“FACC,” Dkt. 66) as well as the present motion requesting leave to file a 27 1 proposed Second Amended Answer & Crossclaim (“SACC,” Dkt. 67-2) against cross- 2 defendants, CHR and TCSL. Mtn. at 1. Defendants seek leave to file new crossclaims 3 for negligence, negligent misrepresentation, conversion, and negligent interference with 4 economic advantage, as well as their previously asserted crossclaims for equitable 5 indemnification, and contribution. Id. at 4. 6 While the parties were briefing the motion for leave to amend, CHR filed a motion 7 to dismiss the FACC on May 11, 2020. Dkt. 68. On May 26, 2020, defendants filed an 8 opposition to CHR’s motion to dismiss. Dkt. 74. While not directly involved in the 9 crossclaim or the motion to dismiss, the opposition contained statements that caused 10 plaintiff to file a motion seeking to address purportedly frivolous allegations in defendants’ 11 opposition brief. Dkt. 75. 13 A. Legal Standard 14 Federal Rule of Civil Procedure 15 requires that a plaintiff obtain either consent of 15 the defendant or leave of court to amend its complaint once the defendant has answered, 16 but “leave shall be freely given when justice so requires.” Fed. R. Civ. P. 15(a); see, e.g., 17 Chodos v. W. Publ’g Co., 292 F.3d 992, 1003 (9th Cir. 2002) (leave to amend granted 18 with “extreme liberality”). Leave to amend is thus ordinarily granted unless the 19 amendment is futile, would cause undue prejudice to the defendants, or is sought by 20 plaintiffs in bad faith or with a dilatory motive. Foman v. Davis, 371 U.S. 178, 182 (1962); 21 Smith v. Pac. Properties & Dev. Corp., 358 F.3d 1097, 1101 (9th Cir. 2004). While courts 22 should consider all such factors, “the crucial factor is the resulting prejudice to the 23 opposing party.” Howey v. United States, 481 F.2d 1187, 1190 (9th Cir. 1973). 24 B. Analysis 25 1. Summary of Defendants’ Proposed Second Amended Answer & 26 Crossclaim 27 While the FACC only brings two claims against TCSL and CHR for indemnification 1 and CHR: (1) negligence; (2) negligent misrepresentation; (3) conversion; (4) negligent 2 interference with economic advantage; (5) equitable indemnification; and (6) contribution. 3 Dkt. 67-2. Because only CHR opposes the motion to amend, the court briefly describes 4 the proposed crossclaims asserted against CHR. 5 Defendants’ first crossclaim for negligence alleges that CHR breached its duty of 6 care when TCSL, acting at the direction of CHR, took goods from defendants it did not 7 have a right to receive or transport. Id. ¶¶ 29–41.2 Defendants’ second crossclaim for 8 conversion alleges that TCSL acted on behalf of CHR when it mishandled the shipment 9 at issue, which caused permanent damage to its contents. Id. ¶¶ 42–48. Defendants’ 10 third crossclaim for negligent misrepresentation alleges that a TCSL employee, who was 11 dispatched at the direction of CHR, orally represented that he was authorized to receive 12 and transport the pharmaceutical products at issue, even though the employee knew he 13 did not have the power to do so. Id. ¶¶ 49–59. Defendants’ fourth crossclaim for 14 negligent interference with prospective economic advantage alleges that the negligent 15 conduct carried out at the direction of CHR prevented defendants from realizing the 16 economic benefits of their contractual relationship with Schein. Id. ¶¶ 60–70. 17 Defendants also re-allege their crossclaims for equitable indemnification and 18 contribution. Id. ¶¶ 71–80. 19 2. Whether Defendants’ Amendment Meets the Requirements of Rule 15 20 Under Rule 15, “[t]he court should freely give leave [to amend the complaint] when 21 justice so requires.” Fed. R. Civ. P. 15(a)(2). This policy is “to be applied with extreme 22 liberality.” Eminence Capital, LLC v. Aspeon, Inc., 316 F.3d 1048, 1051–52 (9th Cir. 23 2003).

Free access — add to your briefcase to read the full text and ask questions with AI

Underwriters at Lloyd's Subscribing to Cover Note B1526MACAR1800089 v. TCSL, Inc., (N.D. Cal. 2020).

Underwriters at Lloyd's Subscribing to Cover Note B1526MACAR1800089 v. TCSL, Inc. (Underwriters at Lloyd's Subscribing to Cover Note B1526MACAR1800089 v. TCSL, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related